Template:Herpes antiviral treatment: Difference between revisions
Neil.m.young (talk | contribs) No edit summary |
Neil.m.young (talk | contribs) No edit summary |
||
| Line 6: | Line 6: | ||
*[[Famciclovir]] 250mg PO q8hrs x 7-10 days | *[[Famciclovir]] 250mg PO q8hrs x 7-10 days | ||
====Recurrence==== | ====Recurrence<ref>Workoski KA and Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommen and Reports. 2015; 64(3):1-140.</ref>==== | ||
*[[Acyclovir]] OR | |||
**400mg PO q8hrs x 5 days | |||
**''or'' 800mg PO q12hrs x 5 days | |||
**''or'' 800mg PO q8hrs x 2 days | |||
*[[Valacyclovir]] OR | *[[Valacyclovir]] OR | ||
**500mg PO q12hrs x 3 days | **500mg PO q12hrs x 3 days | ||
**''or'' 1g PO qd x 5 days | **''or'' 1g PO qd x 5 days | ||
*[[ | *[[Famciclovir]] | ||
* | **125mg PO q12hrs for 5 days | ||
**''or'' 1g PO q12hrs for 1 day | |||
**''or'' 500mg PO once, followed by 250mg PO q12hrs for 2 days | |||
====Suppressive Therapy<ref>Workoski KA and Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommen and Reports. 2015; 64(3):1-140.</ref>==== | ====Suppressive Therapy<ref>Workoski KA and Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommen and Reports. 2015; 64(3):1-140.</ref>==== | ||
Revision as of 06:55, 5 June 2015
Initial Episode[1]
- Acyclovir OR
- 400mg PO q8hrs x 7-10 days
- or 200mg PO 5x/day x 7-10 days
- Valacyclovir 1g PO q12hrs x 7-10 days OR
- Famciclovir 250mg PO q8hrs x 7-10 days
Recurrence[2]
- Acyclovir OR
- 400mg PO q8hrs x 5 days
- or 800mg PO q12hrs x 5 days
- or 800mg PO q8hrs x 2 days
- Valacyclovir OR
- 500mg PO q12hrs x 3 days
- or 1g PO qd x 5 days
- Famciclovir
- 125mg PO q12hrs for 5 days
- or 1g PO q12hrs for 1 day
- or 500mg PO once, followed by 250mg PO q12hrs for 2 days
Suppressive Therapy[3]
- Acyclovir 400mg PO q12hrs daily OR
- Famciclovir 250mg PO q12hrs daily OR
- Valacyclovir 500mg-1g PO daily (500mg may be less effective)
- ↑ Workoski KA and Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommen and Reports. 2015; 64(3):1-140.
- ↑ Workoski KA and Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommen and Reports. 2015; 64(3):1-140.
- ↑ Workoski KA and Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommen and Reports. 2015; 64(3):1-140.